Convenience, efficacy, safety, and durability of INSTI-based antiretroviral therapies: evidence from the Italian MaSTER cohort

BACKGROUND: Integrase strand transferase inhibitors (INSTI), including raltegravir (RAL), elvitegravir (ELV), and dolutegravir (DTG), have demonstrated better efficacy and tolerability than other combination antiretroviral therapy (cART) classes in clinical trials; however, studies of sustainability...

Descripción completa

Detalles Bibliográficos
Autores principales: Rich, Shannan N., Nasta, Paola, Quiros-Roldan, Eugenia, Fusco, Paolo, Tondinelli, Alice, Costa, Cecilia, Fornabaio, Chiara, Mazzini, Nicola, Prosperi, Mattia, Torti, Carlo, Carosi, Giampiero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436514/
https://www.ncbi.nlm.nih.gov/pubmed/37596688
http://dx.doi.org/10.1186/s40001-023-01276-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436514/
https://www.ncbi.nlm.nih.gov/pubmed/37596688
http://dx.doi.org/10.1186/s40001-023-01276-3

Ejemplares similares